AUPN766496A0 - Method and composition for the potentiation of anti-inflammatory drugs - Google Patents

Method and composition for the potentiation of anti-inflammatory drugs

Info

Publication number
AUPN766496A0
AUPN766496A0 AUPN7664A AUPN766496A AUPN766496A0 AU PN766496 A0 AUPN766496 A0 AU PN766496A0 AU PN7664 A AUPN7664 A AU PN7664A AU PN766496 A AUPN766496 A AU PN766496A AU PN766496 A0 AUPN766496 A0 AU PN766496A0
Authority
AU
Australia
Prior art keywords
potentiation
composition
inflammatory drugs
inflammatory
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN7664A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEW ENGLAND THE, University of
Original Assignee
University of New England
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New England filed Critical University of New England
Priority to AUPN7664A priority Critical patent/AUPN766496A0/en
Publication of AUPN766496A0 publication Critical patent/AUPN766496A0/en
Priority to AU12972/97A priority patent/AU1297297A/en
Priority to PCT/AU1997/000035 priority patent/WO1997026889A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
AUPN7664A 1996-01-22 1996-01-22 Method and composition for the potentiation of anti-inflammatory drugs Abandoned AUPN766496A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPN7664A AUPN766496A0 (en) 1996-01-22 1996-01-22 Method and composition for the potentiation of anti-inflammatory drugs
AU12972/97A AU1297297A (en) 1996-01-22 1997-01-22 Method and composition for the potentiation of anti-inflammatory drugs
PCT/AU1997/000035 WO1997026889A1 (en) 1996-01-22 1997-01-22 Method and composition for the potentiation of anti-inflammatory drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN7664A AUPN766496A0 (en) 1996-01-22 1996-01-22 Method and composition for the potentiation of anti-inflammatory drugs

Publications (1)

Publication Number Publication Date
AUPN766496A0 true AUPN766496A0 (en) 1996-02-15

Family

ID=3791982

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN7664A Abandoned AUPN766496A0 (en) 1996-01-22 1996-01-22 Method and composition for the potentiation of anti-inflammatory drugs

Country Status (2)

Country Link
AU (1) AUPN766496A0 (en)
WO (1) WO1997026889A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
WO2005030226A1 (en) * 2003-09-25 2005-04-07 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes
MA46207A (en) 2016-09-09 2019-07-17 Int Agriculture Group Llc ALTERNATIVE TO NATURAL COCOA AND ITS PRODUCTION PROCESSES
WO2018049242A1 (en) 2016-09-09 2018-03-15 International Agriculture Group, LLC Yogurt product from high starch fruits

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2856333C2 (en) * 1978-12-27 1983-09-22 A. Nattermann & Cie GmbH, 5000 Köln Oral medicines with anti-inflammatory effects
JPS58150508A (en) * 1982-03-02 1983-09-07 Mitsubishi Chem Ind Ltd Preparation for skin
DE3346526C2 (en) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmaceutical preparation for the therapeutic treatment of rheumatic diseases
JPS6348226A (en) * 1986-08-14 1988-02-29 Ono Pharmaceut Co Ltd Slowly releasing solid preparation for oral administration
WO1991016920A1 (en) * 1990-05-07 1991-11-14 Vical, Inc. Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
JP3131282B2 (en) * 1991-11-12 2001-01-31 ポーラ化成工業株式会社 Anti-inflammatory analgesic external preparation
JP3215133B2 (en) * 1991-11-12 2001-10-02 ポーラ化成工業株式会社 Anti-inflammatory analgesic external preparation
JP3280071B2 (en) * 1992-05-27 2002-04-30 ポーラ化成工業株式会社 Anti-inflammatory analgesic external preparation
JP3208719B2 (en) * 1992-05-28 2001-09-17 ポーラ化成工業株式会社 Anti-inflammatory analgesic external preparation

Also Published As

Publication number Publication date
WO1997026889A1 (en) 1997-07-31

Similar Documents

Publication Publication Date Title
AU1618697A (en) Novel compounds and pharmaceutical use thereof
AUPN605795A0 (en) Analgesic pharmaceutical composition
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU1429397A (en) Labeled vitamin d compounds and the use thereof
AU5136998A (en) Medicinal composition
AU2655097A (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
AU2670897A (en) Fibulin pharmaceutical compositions and related methods
AU5155096A (en) Pharmaceutical composition
AU4843996A (en) Imidazole derivatives and medicinal composition thereof
AUPO359396A0 (en) A method of treatment and pharmaceutical compositions useful for same
AU7001496A (en) Anti-inflammatory agent
AU7275894A (en) Imidazolylalkylamine derivative and pharmaceutical composition thereof
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof
AUPN766496A0 (en) Method and composition for the potentiation of anti-inflammatory drugs
AU6257796A (en) Composition and method for administration of bio-affecting c atalysts
AU6690394A (en) Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof
AU3107497A (en) Asialotrisaccharide moranoline derivatives and drugs
AU7681498A (en) Pharmaceutical composition and use thereof
AU1297297A (en) Method and composition for the potentiation of anti-inflammatory drugs
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
AU8038298A (en) Triterpene derivatives and medicinal composition
AUPN064095A0 (en) Method and composition for the potentiation of anti-inflammatory drugs
AU1195597A (en) Dibenzothiepin derivatives and pharmaceutical compositions
AU2452797A (en) Interferon-gamma anti-inflammatory methods, compounds, and pharmaceutical compositions